News

Accelerated Cure Project Welcomes Cristal Balis as New Marketing Director

Accelerated Cure Project Welcomes Cristal Balis as New Marketing Director

Accelerated Cure Project Welcomes Cristal Balis

Cristal Balis has been appointed as the first director of marketing and communications for the Accelerated Cure Project for Multiple Sclerosis (ACP). This appointment marks a significant milestone for the organization as it approaches its 25th year of working towards innovative solutions for those affected by multiple sclerosis (MS).

Strategic Commitment to Outreach and Engagement

The addition of Balis to the ACP team underscores the organization's strategic commitment to expanding its influence and support for the MS community. In her new role, Balis will spearhead marketing strategies, brand development, and digital communications, aiming to enhance both ACP's visibility and the reach of their iConquerMS initiative—an unprecedented research network powered by individuals living with MS.

Enhanced Visibility and Mission-Driven Storytelling

Balis is expected to play a crucial role in elevating the organization's presence among various stakeholders, including patients, researchers, and funding partners. With a focus on community-centered research, her work will help ensure that the mission-driven narrative of ACP resonates strongly with existing and new audiences.

A Wealth of Experience

Balis comes to ACP with a diverse background that blends nonprofit storytelling with strategic communication expertise. She was previously part of a senior leadership team at The Emancipator, a nonprofit media platform dedicated to racial equity, developed in collaboration with The Boston Globe and Boston University. Her expansive career also includes significant contributions to nonprofit entities such as Howard Brown Health Center and notable global advertising firms.

Leadership Insights from the CEO

Sara Loud, CEO of Accelerated Cure Project, praised Balis for her unique blend of vision and creativity. According to Loud, Balis’s leadership is poised to help ACP reach new audiences while nurturing existing relationships, making sure that the MS community is aware of the impactful work being done through ACP and iConquerMS.

Shining a Brighter Light on ACP's Impact

Expressing her enthusiasm for her new role, Balis noted the remarkable history of ACP and its nearly 25 years of transformative work aimed at accelerating MS research and improving outcomes for those impacted by the disease. She emphasized her commitment to amplifying the organization's efforts and ensuring that its research initiatives reflect the diverse experiences within the MS community.

Expanding Research Initiatives and Partnerships

As ACP looks to expand its research initiatives and strengthen its relationships within the MS ecosystem, Balis’s appointment comes at a crucial time. With over a million Americans living with MS, this leadership change signifies a renewed focus on deepening engagement with these individuals and enhancing the effectiveness of their research initiatives.

About Accelerated Cure Project

Accelerated Cure Project (ACP) is a nonprofit organization founded by patients dedicated to advancing research that enhances the health and quality of life for those affected by multiple sclerosis. By fostering scientific collaboration and providing essential resources, ACP is on the forefront of enabling researchers to explore new avenues in the fight against MS. Key programs include the ACP Repository and the iConquerMS People-Powered Research Network.

Contact Information

For further inquiries, please reach out to:
Lindsey Santiago

Frequently Asked Questions

Who is Cristal Balis?

Cristal Balis is the newly appointed Director of Marketing and Communications for the Accelerated Cure Project.

What does the Accelerated Cure Project focus on?

The Accelerated Cure Project focuses on advancing MS research and improving health outcomes for individuals affected by multiple sclerosis.

What is iConquerMS?

iConquerMS is a unique research initiative powered by individuals living with MS that aims to drive patient-centered research.

Why is Balis's appointment significant for ACP?

Balis's role enhances ACP's strategy for expanding outreach and engagement within the MS community.

How does ACP contribute to MS research?

ACP promotes scientific collaboration and provides critical resources to researchers, facilitating novel research that can lead to better care and potential cures for MS.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Veritran's Bold Move: Acquiring PrismaCampaigns Inc.

Updated Category News Views 111

Veritran's Strategic Leap Forward They're not messing around, folks. Veritran just made a power move by acquiring 100% of PrismaCampaigns Inc., and it’s more than just another day in the office. This marks a pivotal expansion of their American footprint, and they're zeroing in on our banks and credit unions with laser precision. Why This Matters for Financial...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 161

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Teledyne LeCroy Drives AI Scale-up with New UALink

Updated Category News Views 99

Pushing the Boundaries of AI Infrastructure Teledyne LeCroy is shaking things up with their latest innovation—the Xena Z2244 Ultra Accelerator Link™ Traffic Generator, a tool that promises to turbocharge validation systems for AI and HPC scale-up infrastructure. If you're dealing with the nuts and bolts of next-gen networks, this one's worth your attention. Setting a...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 210

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
NeuroPace Faces Investigation After Revenue Forecast Cut

Updated Category News Views 35

NeuroPace Revenue Drama: A Blow to Investor Confidence How the mighty have stumbled—or so it feels to the folks who put their bucks into NeuroPace, Inc. (NASDAQ: NPCE). It's tough to swallow: they cut their 2026 revenue forecast from a hopeful $99.5-$101.5 million to a sobering $91-$92 million. Just one quarter apart those projections are, like a cruel twist of fate...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 128

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 71

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Ontario Airport Braces for Holiday Travel Surge

Updated Category News Views 126

Gearing Up for a Thanksgiving Travel Boom Think Thanksgiving brings only turkey to the table? Down in Ontario, California, it's all about jet fuel and passenger counts. The Ontario International Airport (ONT) is where the skies are buzzing, forecasting over 227,000 passengers trying to soak up the holiday vibes by air. Compare that to the numbers when the local folks...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 203

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading

Top 5 Most Recently Viewed Articles

Tesla Faces Sales Challenges in Europe Amidst Controversies

Updated Category News Views 428

Tesla's Declining Sales in Key European Markets Tesla Inc (NASDAQ: TSLA) is facing significant sales declines in several European countries as reported in early 2025. These drops, drastic in some cases, seem to be a reflection of growing consumer dissatisfaction linked to CEO Elon Musk's heightened political involvement. The Impact of Elon Musk's Political Engagement As...

Continue Reading
How CareMessage's Wellness Copilot Enhances Diabetes Care

Updated Category News Views 141

Innovative Solutions for Diabetes Care Enhancement CareMessage, a pioneering non-profit organization, recently introduced the Wellness Copilot aimed at transforming diabetes management for vulnerable populations. The initiative comes at a crucial time when many healthcare systems are struggling to meet the demands of an ever-growing diabetic population across the country....

Continue Reading
MEDIROM Healthcare Technologies Announces Major Public Offering

Updated Category News Views 269

MEDIROM Healthcare Technologies Inc. Pricing Public Offering MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) has announced a significant step forward in its growth strategy by pricing a public offering of American Depositary Shares. This offering involves 2,860,000 shares priced at $1.75 each, totaling gross proceeds of around $5,000,000. The company is anticipating...

Continue Reading
Dreame's LEAPTIC Cube: Revolutionizing Action Cameras Today

Updated Category News Views 201

Dreame Unveils the LEAPTIC Cube: The Future of Action Cameras At CES 2026 in Las Vegas, Dreame Technology proudly introduced the LEAPTIC Cube, the company's first 8K AI action camera. This innovative release signifies a remarkable advancement in portable imaging, tailored for content creators, adventurers, and professionals seeking exceptional performance in a compact...

Continue Reading
Two Hands Corporation's Significant Shareholder Meeting Update

Updated Category News Views 294

Two Hands Corporation Reports on Special Meeting Outcomes Two Hands Corporation (CSE: TWOH.X) (OTC: TWOH) recently held a significant special meeting for its shareholders. This gathering served as a platform to discuss vital changes affecting the company's structure and stock distribution. Highlights from the Special Meeting During the meeting, shareholders voted to...

Continue Reading